Skip to content

Clinical trials

alpha 1-Antitrypsin Deficiency trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: alpha 1-Antitrypsin Deficiency Country / region: Australia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20081
20141
20151
20162
20211
20232
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Terminated4
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baxalta now part of Shire3
CSL Behring2
Grifols Therapeutics LLC2
Sanofi2
AIRNA Corporation1
Arrowhead Pharmaceuticals1
Beam Therapeutics Inc.1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Korro Bio, Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
alpha 1-Antitrypsin Deficiency17
Emphysema5
Pulmonary Emphysema2
Congenital Abnormalities1
Genetic Diseases, Inborn1
Infant, Newborn, Diseases1
Liver Diseases1
Lung Diseases1
Pathologic Processes1
Pathological Conditions, Signs and Symptoms1

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.